Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Single Agent AZD2014 in RICTOR Amplified or Over-expressed GC Patients as Second-line Therapy

NCT03061708 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03061708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03061708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Single Agent AZD2014 in RICTOR Amplified or Over-expressed GC Patients as Second-line Therapy
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
February 1, 2017
Completion date
November 16, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasms